李雯馨, 徐琛. ACR CEUS LI-RADS在有无高危风险人群中对肝细胞癌的诊断价值. 2026. biomedRxiv.202601.00041
ACR CEUS LI-RADS在有无高危风险人群中对肝细胞癌的诊断价值
通讯作者: 徐琛, ccdyx77@163.com
DOI:10.12201/bmr.202601.00041
Diagnostic value of ACR CEUS LI-RADS for hepatocellular carcinoma in high-risk and non-high-risk populations
Corresponding author: Xu Chen, ccdyx77@163.com
-
摘要:目的 探讨超声造影肝脏影像报告与数据系统(LI-RADS)在高危风险人群与非高危风险人群中对肝细胞癌(HCC)的诊断价值。 方法 回顾性分析538例肝内局灶性病变患者超声造影结果,参考ACR CEUS LI-RADS标准,将是否具有HCC高危因素(肝硬化、慢性乙型病毒性肝炎、HCC既往史等)分为高危风险组和非高危风险组,并对病灶进行分级,以手术或穿刺病理作为最终的结果,评价ACR CEUS LI-RADS在高危及非高危人群的诊断价值。 结果 高危风险组309例,非高危风险组229例,两组以LR-5/M类诊断恶性肿瘤灵敏度分别为90.2%、94.7%,AUC分别为0.824(95%CI:0.752~895)、0.807(95%CI:0.739~0.875); LR-5类诊断HCC灵敏度分别为60.4%、64.7%,特异度分别为96.1%、98.6%,阳性预测值分别为93.9%、78.6%, AUC分别为0.783(95%CI:0.729~0.836)、0.816(95%CI:0.676~0.957);LR-M类诊断肝脏其他恶性肿瘤(OM)灵敏度分别为94.0%、93.2%,AUC分别为0.850(95%CI:0.806~0.895)、0.809(95%CI:0.746~0.871)。 结论 ACR CEUS LI-RADS LR-5/M类在高危风险组和非高危风险组的应用可以初步诊断病灶良恶性,LR-5类在高危风险组诊断HCC具有较高诊断价值,LR-M类在高危风险组和非高危风险组鉴别诊断HCC与OM具有高灵敏度。
Abstract: Objective To evaluate the diagnostic value of the contrast-enhanced ultrasound liver imaging reporting and data system (CEUS LI-RADS) for hepatocellular carcinoma (HCC) in high-risk and non-high-risk populations. Methods Retrospectively analyzed the ultrasound contrast imaging results of 538 patients with intrahepatic focal lesions, referring to the ACR CEUS LI-RADS criteria, grouping into high-risk and non-high-risk categories based on HCC risk factors (cirrhosis, chronic HBV hepatitis, HCC history, etc.), and grading the lesions. Then assessing the diagnostic value of ACR CEUS LI – RADS in high-risk and non-high-risk populations by comparing with final surgical or biopsy pathology outcomes. Results The high-risk group comprised 309 cases, and the non-high-risk group 229. Using the LR-5/M categories for diagnosing malignant tumors, the sensitivities in diagnosing malignant tumors with LR-5/M classification were 90.2% and 94.7%, with AUC values 0.783(95%CI:0.729~0.836) and 0.807(95%CI:0.739~0.875)respectively. For LR-5 HCC diagnosis, sensitivity was 60.4% in the high-risk group and 64.7% in the non-high-risk group, specificity was 96.1% and 98.6%, positive predictive value was 93.9% and 78.6%, with AUC values 0.783 (95% CI: 0.729~0.836) and 0.816 (95%CI:0.676~0.957) respectively. For LR-M classification in diagnosing other hepatic malignancies (OM), the sensitivity was 94.0% and 93.2%, with AUC values 0.850 (95%CI:0.806~0.895) and 0.809 (95%CI:0.746~0.871) respectively. Conclusion The application of the LR-5/M categories in both high-risk and non-high-risk groups can provide an initial assessment of whether a lesion is benign or malignant. LR-5 is highly valuable for HCC diagnosis in high-risk patients. while LR-M shows high sensitivity in differentiating HCC from other malignancies across both groups.
Key words: Contrast-enhanced ultrasound,Liver image report and data management system ,Malignant ,Hepatocellular carcinoma; ; ;提交时间:2026-01-14
版权声明:作者本人独立拥有该论文的版权,预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。 -
图表
-
杨迎青, 钱厉海, 孔祥海. 肌骨超声结合超声造影在肩袖损伤诊断中的应用价值. 2024. doi: 10.12201/bmr.202411.00050
陈辉, 刘若利, 朱雪莲, 金宣辰, 林文雅, 谢作流. 超声造影在睾丸肿块鉴别诊断中的临床应用价值. 2025. doi: 10.12201/bmr.202502.00061
陈惠怡, 路明, 钟培松, 任洪磊, 殷方兰▲. 肝癌早期筛查的精准化研究进展. 2025. doi: 10.12201/bmr.202512.00013
钱 煜, 杨 芳, 张 霞. 超声BI-RADS分类联合PLR、NLR对乳腺肿块良恶性的鉴别诊断价值. 2026. doi: 10.12201/bmr.202603.00001
何景梅, 张晓玲, 陈琨. 系统性炎症反应指数、乳酸脱氢酶及谷草转氨酶用于识别成人暴发性心肌炎高危人群的价值分析. 2024. doi: 10.12201/bmr.202410.00070
肖亚轩, 王雅静, 彭佩, 张雪. 基于“肠道菌群-胆汁酸”轴探讨肝癌肝郁脾虚的病机实质. 2025. doi: 10.12201/bmr.202506.00030
蔡小继. 浙江嘉兴地区女性高危型人乳头瘤病毒亚型的分布情况及高危因素的分析. 2025. doi: 10.12201/bmr.202502.00011
贺明敏, 汪玲莉. 基于“伏邪”理论探讨高危型HPV持续性感染的病因病机和防治思路. 2025. doi: 10.12201/bmr.202510.00027
索源, 孙辉. 电针联合抗血栓压力带对神经危重症高危VTE患者DVT的预防价值. 2025. doi: 10.12201/bmr.202503.00088
石秋钰, 韩萱, 曹丽. 颈动脉超声在评估缺血性血管疾病风险中的研究进展. 2025. doi: 10.12201/bmr.202510.00060
-
序号 提交日期 编号 操作 1 2026-01-07 10.12201/bmr.202601.00041V1
下载 -
-
公开评论 匿名评论 仅发给作者
引用格式
访问统计
- 阅读量:139
- 下载量: 0
- 评论数:0

登录
注册




京公网安备